Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04009005 · ClinicalTrials.gov registry record · NA
Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
A NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome, sponsored by Terry L. Wahls.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT04009005 is a NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome that is active but no longer recruiting, run by Terry L. Wahls. The registered enrollment target is 44 participants, below the 201-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04009005, a NA study of Relapsing Remitting Multiple Sclerosis and Clinically Isolated Syndrome, is active but no longer recruiting, sponsored by Terry L. Wahls.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
A key question in efforts to reduce symptoms and improve quality of life for multiple sclerosis (MS) patients is whether a therapeutic lifestyle (diet, stress reduction and exercise) is inferior to disease-modifying drug treatments in terms of reducing multiple sclerosis related symptoms, improving function and quality of life. This study will prospectively assess the changes in quality of life and clinical outcomes in two cohorts of patients who are recently diagnosed with clinically isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS) to begin answering that question. The goal of this project is to compare a diet and therapeutic lifestyle only treatment usual care in the setting of newly diagnosed individuals with RRMS or CIS, which is the precursor to the development of MS. Due to the COVID 19 Pandemic, the study was redesigned from an in-person study to a virtual visit only study prior to enrolling study subjects.
Conditions Studied
Interventions
- BEHAVIORAL Therapeutic diet and lifestyle
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2020-05-01 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04009005
The ClinicalTrials.gov registry entry for NCT04009005 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 25 other Relapsing Remitting Multiple Sclerosis trials with a reported enrollment target (78% lower). The listed sponsor is Terry L. Wahls, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Relapsing Remitting Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Therapeutic diet and lifestyle is the first listed.
NCT04009005 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT04009005 about?
NCT04009005 is a clinical study titled "Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis". A key question in efforts to reduce symptoms and improve quality of life for multiple sclerosis (MS) patients is whether a therapeutic lifestyle (diet, stress reduction and exercise) is inferior to disease-modifying drug treatments in terms of reducing multiple sclerosis related symptoms, improving ...
What is the current status of trial NCT04009005?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2020-05-01. Estimated completion is 2027-09-01.
What conditions does trial NCT04009005 study?
This clinical trial studies the following conditions: Relapsing Remitting Multiple Sclerosis, Clinically Isolated Syndrome.
What interventions are being tested in trial NCT04009005?
The interventions under investigation include: Therapeutic diet and lifestyle (BEHAVIORAL).
Who is sponsoring clinical trial NCT04009005?
This trial is sponsored by Terry L. Wahls, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04009005 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Relapsing Remitting Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
RECRUITING · NA
-
Functional Outcomes From Diets in Multiple Sclerosis
RECRUITING · NA
-
Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)
COMPLETED · NA
-
Development of a Motivational Intervention to Improve Treatment Adherence in MS
COMPLETED · NA
-
Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms
RECRUITING
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.